SEARCH

SEARCH BY CITATION

References

  • 1
    Leimgruber PP, Roubin GS, Hollman J, et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986; 73: 710717.
  • 2
    Haude M, Konorza TF, Kalnins U, et al. Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients. Circulation 2003; 107: 12651270. DOI: 10.1161/01.CIR.0000053442.64637.34.
  • 3
    Holmes DR Jr. In-stent restenosis. Rev Cardiovasc Med 2001; 2: 115119.
  • 4
    Danzi GB, Sesana M, Capuano C, Predolini S, Baglini R. Restenosis after NIR stent implantation. Minerva Cardioangiol 2002; 50: 455462.
  • 5
    Wilensky RL, March KL, Gradus-Pizlo I, Sandusky G, Fineberg N, Hathaway DR. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation 1995; 92: 29953005.
  • 6
    Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403409. DOI: 10.1038/nm0402-403.
  • 7
    Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element “decoy” against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997; 3: 894899.
  • 8
    Suzuki J, Morishita R, Amano J, Kaneda Y, Isobe M. Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts. Gene Ther 2000; 7: 18471852.
  • 9
    Yoshimura S, Morishita R, Hayashi K, et al. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element ‘decoy’ of nuclear factor-kappaB binding site as a novel molecular strategy. Gene Ther 2001; 8: 16351642.
  • 10
    Yamasaki K, Asai T, Shimizu M, et al. Inhibition of NF-κB activation using cis-element “decoy” of NF-κB binding site reduces neointimal formation in porcine balloon-injured coronary artery model. Gene Ther 2003; 10: 356364. DOI: 10.1038/sj.gt.3301875.
  • 11
    Morishita R. Recent progress in gene therapy for cardiovascular disease. Circ J 2002; 66: 10771086. DOI: 10.1253/circj.66.1077.
  • 12
    Luscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007; 115: 10511058. DOI: 10.1161/CIRCULATIONAHA.106.675934.
  • 13
    Pasceri V, Patti G, Speciale G, Pristipino C, Richichi G, Di Sciascio G. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 2007; 153: 749754.
  • 14
    Leon MB. Late thrombosis a concern with drug-eluting stents. J Interv Cardiol 2007; 20: 2629. DOI: 10.1111/j.1540–8183.2007.00225.x.
  • 15
    Squadrito F, Deodato B, Bova A, et al. Crucial role of nuclear factor-kappaB in neointimal hyperplasia of the mouse carotid artery after interruption of blood flow. Atherosclerosis 2003; 166: 233242. DOI: 10.1016/S0021-9150(02)00336-2.
  • 16
    Yokoseki O, Suzuki J, Kitabayashi H, et al. cis element decoy against neculear factor-kB attenuates development of experimental autoimmune myocarditis in rats. Circ Res 2001; 89: 899906. DOI: 10.1161/hh2201.099373.
  • 17
    Matsushita H, Morishita R, Nata T, et al. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circ Res 2000; 86: 974981.
  • 18
    Miyake T, Aoki M, Shiraya S, et al. Inhibitory effects of NF-κB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J Mol Cell Cardiol 2006; 41: 431440. DOI: 10.1016/j.yjmcc.2006.04.006.
  • 19
    Oshima S, Ogawa H, Hokimoto S, et al. Plasma monocyte chemoattractant protein-1 antigen levels and the risk of restenosis after coronary stent implantation. Jpn Circ J 2001; 65: 261264. DOI: 10.1253/jcj.65.261.
  • 20
    Ohtani K Egashira K, Nakano K, et al. Stent-based local delivery of nuclear factor-kappaB decoy attenuates in-stent restenosis in hypercholesterolemic rabbits. Circulation 2006; 114: 27732779. DOI: 10.1161/CIRCULATIONAHA. 105.582254.
  • 21
    Egashira K, Nakano K, Ohtani K, et al. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys. Arterioscler Thromb Vasc Biol 2007; 27: 25632568. DOI: 10.1161/ATVBAHA.107.154609.